Stonehage Fleming Financial Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35
Closed -$823 283
2024
Q1
$823 Hold
35
﹤0.01% 175
2023
Q4
$504 Hold
35
﹤0.01% 227
2023
Q3
$607 Hold
35
﹤0.01% 243
2023
Q2
$728 Hold
35
﹤0.01% 196
2023
Q1
$823 Hold
35
﹤0.01% 175
2022
Q4
$978 Hold
35
﹤0.01% 172
2022
Q3
$0 Buy
+35
New +$1.06K ﹤0.01% 238
2021
Q3
Sell
-100
Closed -$3K 227
2021
Q2
$3K Buy
+100
New +$3.29K ﹤0.01% 205

Other funds holding OGN

Stonehage Fleming Financial Services's OGN Position: Q2 2024 in Review

Stonehage Fleming Financial Services sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 35 shares — an estimated $823 sold.

Stonehage Fleming Financial Services first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $3K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Stonehage Fleming Financial Services reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 35 Organon & Co shares in Q2 2024, an estimated $823.
  • Stonehage Fleming Financial Services first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Stonehage Fleming Financial Services's Organon & Co position peaked at $3K in Q2 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2024, filed 5 Aug 2024.